116 related articles for article (PubMed ID: 21546630)
1. The safety record of fusidic acid in non-US markets: a focus on skin infections.
Kraus CN; Burnstead BW
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S527-37. PubMed ID: 21546630
[TBL] [Abstract][Full Text] [Related]
2. Fusidic acid in dermatology: an updated review.
Schöfer H; Simonsen L
Eur J Dermatol; 2010; 20(1):6-15. PubMed ID: 20007058
[TBL] [Abstract][Full Text] [Related]
3. Efforts to support the development of fusidic acid in the United States.
Fernandes P; Pereira D
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S542-6. PubMed ID: 21546632
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the efficacy and toxicity of local fusidic aid versus oral dicloxacillin in infections of the skin].
Macotela-Ruiz E; Durán Bermúdez H; Kuri Con FJ; Arevalo López A; Villalobos Ibarra JL
Med Cutan Ibero Lat Am; 1988; 16(2):171-3. PubMed ID: 3050336
[TBL] [Abstract][Full Text] [Related]
5. Fusidic acid in skin and soft tissue infections.
Spelman D
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S59-66. PubMed ID: 10528787
[TBL] [Abstract][Full Text] [Related]
6. In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States.
Jones RN; Mendes RE; Sader HS; Castanheira M
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S477-86. PubMed ID: 21546624
[TBL] [Abstract][Full Text] [Related]
7. Introduction: fusidic acid enters the United States.
Moellering RC; Corey GR; Grayson ML
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S467-8. PubMed ID: 21546622
[No Abstract] [Full Text] [Related]
8. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
[TBL] [Abstract][Full Text] [Related]
9. Fusidic acid plus betamethasone in infected or potentially infected eczema.
Hjorth N; Schmidt H; Thomsen K
Pharmatherapeutica; 1985; 4(2):126-31. PubMed ID: 3903779
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and safety of single, multiple, and loading doses of fusidic acid in healthy subjects.
Still JG; Clark K; Degenhardt TP; Scott D; Fernandes P; Gutierrez MJ
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S504-12. PubMed ID: 21546627
[TBL] [Abstract][Full Text] [Related]
11. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
Howden BP; Grayson ML
Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.
Pfaller MA; Castanheira M; Sader HS; Jones RN
Int J Antimicrob Agents; 2010 Mar; 35(3):282-7. PubMed ID: 20036520
[TBL] [Abstract][Full Text] [Related]
13. Case report: treatment of chronic osteomyelitis.
Wolfe CR
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S538-41. PubMed ID: 21546631
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options.
Welte T; Pletz MW
Int J Antimicrob Agents; 2010 Nov; 36(5):391-400. PubMed ID: 20724119
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
[TBL] [Abstract][Full Text] [Related]
16. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use.
Sule O; Brown NM; Willocks LJ; Day J; Shankar S; Palmer CR; Burrows NP
Int J Antimicrob Agents; 2007 Jul; 30(1):78-82. PubMed ID: 17475448
[TBL] [Abstract][Full Text] [Related]
17. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds.
Ulkür E; Oncul O; Karagoz H; Yeniz E; Celiköz B
Burns; 2005 Nov; 31(7):874-7. PubMed ID: 16011879
[TBL] [Abstract][Full Text] [Related]
18. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial.
Filippi L; Pezzati M; Di Amario S; Poggi C; Pecile P
Pediatr Crit Care Med; 2007 Nov; 8(6):556-62. PubMed ID: 17914310
[TBL] [Abstract][Full Text] [Related]
19. Generalized urticaria to fusidic acid.
Bobadilla-González P; García-Menaya JM; Cordobés-Durán C; Pérez-Rangel I; Sánchez-Vega S
Allergy; 2009 May; 64(5):817-8. PubMed ID: 19187392
[No Abstract] [Full Text] [Related]
20. [Effectiveness of fusidic acid alone and in combination with hydrocortisone-17-butyrate in infected dermatoses].
Enderer K; Höffler U
Z Hautkr; 1984 Feb; 59(3):151-4. PubMed ID: 6719973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
